Randomized controlled trial2024

Effects of time-restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease

Deng Y, Liu X, Sun Y, Zhou L, Li Q, Lei Z, Yang F, Chen L, Zhang C, Tan W, Jin X, Han Z, Xu H, Wang Q, Nie Q, Yi H, Bao W, Rong S

Obesity (Silver Spring, Md.) · 15 citations

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Independent funding
Government
National Natural Science Foundation of China
University or hospital
Wuhan University
University or hospital
Wuhan University of Science and Technology
Grants
National Natural Science Foundation of China (82073552); National Natural Science Foundation of China (82373575); National Natural Science Foundation of China (82204038)

Based on 3 listed funder(s).

Publication

Published
2024-01-16 · Obesity (Silver Spring) · vol. 32 · issue 3 · pp. 494–505
Publisher
Wiley
Cited
22 citations · more than 96% of similar papers · 5.0× the field average
Impact
Top 10% most cited in its field
References
43 works
Access
Free to read
Research areas
Dietary Effects on Health · Liver Disease Diagnosis and Treatment · Diet, Metabolism, and Disease
Keywords
Nonalcoholic fatty liver disease, Medicine, Internal medicine, Fatty liver, Gastroenterology, Liver function, Randomization, Randomized controlled trial, Obesity, Endocrinology, Disease
MeSH
liver, humans, magnetic resonance imaging, body composition, adult, non-alcoholic fatty liver disease

18 authors

From CN, HK

  • Yan DengWuhan University of Science and Technology
  • Xiaoming LiuUnion Hospital; Wuhan Union Hospital; Huazhong University of Science and Technology
  • Yuzhe SunBGI Group (China); Beijing Graphene Institute; BGI Research
  • Li ZhouWuhan University of Science and Technology
  • Qiang LiUnion Hospital; Wuhan Union Hospital; Huazhong University of Science and Technology
  • Ziqiao LeiUnion Hospital; Wuhan Union Hospital; Huazhong University of Science and Technology

Abstract

Objective

The study's objective was to explore whether early time-restricted eating (eTRE) and late time-restricted eating (lTRE) have different impacts on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease (NAFLD).

Methods

This is an 8-week, randomized, parallel-arm, open-label trial. Forty eligible patients were randomly assigned to eTRE (eating between 8:00 a.m. and 4:00 p.m.) or lTRE (eating between 12:00 p.m. and 8:00 p.m.). The primary outcome was the change of intrahepatic fat measured by magnetic resonance image-derived proton density fat fraction. Secondary outcomes included changes in weight, body composition, liver function, and cardiometabolic factors.

Results

Forty participants who underwent randomization completed the trial (mean age: 38.25 years). The eTRE group had a -3.24% absolute reduction of intrahepatic fat (95% CI: -4.55% to -1.92%) and there was a -3.51% absolute reduction for the lTRE group (95% CI: -5.10% to -1.92%). Changes in intrahepatic fat were not statistically different between the two groups. Both the eTRE and lTRE groups had similar and significant reductions in weight, visceral fat, subcutaneous fat, liver enzymes, and glucose regulatory indicators.

Conclusions

Among patients with NAFLD, both eTRE and lTRE induced significant reductions in intrahepatic fat and improvements in body composition, liver function, and metabolic health with similar magnitude. These findings suggest that eTRE and lTRE are comparable and feasible strategies for NAFLD management.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.